Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secondary Prevention of Small Subcortical Strokes
2005-003242-34Phase 3Completed
- Sponsor
- National Institutes of Neurological Disorders: Stroke
- Start
- Sep 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in lacunar infarct and Small-Vessel Occlusion (SVO) comparing Aspirin + clopidogrel with Aspirin alone (2 arms). Primary endpoint: First occurrence of any stroke. Started Sep 2012; status: completed.
02
Drugs
aspirinclopidogrel
03
Conditions
lacunar infarctSmall-Vessel Occlusion (SVO)
Beyond the preview
Go deeper on 2005-003242-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003242-34.